The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?

Affiliations

¹ Department of Genetic Medicine and Development, University Medical Centre, 1 rue Michel-Servet, 1211, Geneva 4, Switzerland. philippe.halban@medecine.unige.ch.

P A Halban. Diabetologia. 2007 Sep.

. 2007 Sep;50(9):1791-1794.

doi: 10.1007/s00125-007-0740-y. Epub 2007 Jul 5.

¹ Department of Genetic Medicine and Development, University Medical Centre, 1 rue Michel-Servet, 1211, Geneva 4, Switzerland. philippe.halban@medecine.unige.ch.

No abstract available

Similar articles

The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level.
Kamel N, Compton C, Middelveld R, Higenbottam T, Dahlén SE. Kamel N, et al. Eur Respir J. 2008 May;31(5):924-6. doi: 10.1183/09031936.00033208. Eur Respir J. 2008. PMID: 18448501 No abstract available.
[The Innovative Medicine Initiative (IMI)].
Bril A, Canet E. Bril A, et al. Med Sci (Paris). 2008 Oct;24(10):885-90. doi: 10.1051/medsci/20082410885. Med Sci (Paris). 2008. PMID: 18950588 French.
The innovative medicines initiative: a European response to the innovation challenge.
Goldman M. Goldman M. Clin Pharmacol Ther. 2012 Mar;91(3):418-25. doi: 10.1038/clpt.2011.321. Epub 2012 Feb 8. Clin Pharmacol Ther. 2012. PMID: 22318619 Review.
The Innovative Medicines Initiative moves translational immunology forward.
Goldman M, Wittelsberger A, De Magistris MT. Goldman M, et al. Eur J Immunol. 2013 Feb;43(2):298-302. doi: 10.1002/eji.201370024. Eur J Immunol. 2013. PMID: 23534061 Review.
Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
Gaspar R, Aksu B, Cuine A, Danhof M, Takac MJ, Linden HH, Link A, Muchitsch EM, Wilson CG, Ohrngren P, Dencker L. Gaspar R, et al. Eur J Pharm Sci. 2012 Dec 18;47(5):979-87. doi: 10.1016/j.ejps.2012.09.020. Epub 2012 Oct 6. Eur J Pharm Sci. 2012. PMID: 23046836